tirzepatide v semaglutide vs Tirzepatide vs. Semaglutide: Which GLP-1

These genetic markers may provide clinical context for understanding individual differences in sensitivity to GLP-1 activation and potential neurological side effects

Type 2 diabetes occurs when a person cannot create enough insulin for the body to function, or their cells are not sensitive to insulin meaning they need more of it than normal

Yang Z, Wafula EK, Honaas LA, Zhang H, Das M, Fernandez-Aparicio M, et al

So far, trials involve a small number of participants and effectiveness tends to rely heavily on the quality of encapsulation

Signs you may need to decrease dose: persistent injection site reactions, nausea, fatigue, or excessive skin sensitivity

CsA attenuates compression-induced nucleus pulposus mesenchymal stem cells apoptosis via alleviating mitochondrial dysfunction and oxidative stress